-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
-
Q&A
The Legacy of Henrietta LacksAuthor Rebecca Skloot reflects on the contributions of one woman to science and the importance of informed consent in human research.
by Alexandra Goho
-
Forward Look
Orphan Drugs Still Find a HomeThirty years on, landmark federal legislation continues to benefit patients with rare cancers.
by Emily Gertz
-
Survivor Profile
Let’s Talk: Lee MillerDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
-
Survivor Profile
Patients’ Rights PowerhouseMyra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
-
Forward Look
Confronting Lung Cancer StigmaAn ad campaign shines a light on lung cancer blame.
by Yvonne Lee
-
Yesterday & Today
The Sex Machine vs. Prostate CancerEven cancer couldn't slow down James Brown.
by Jocelyn Selim
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
-
Teaming Up for Better TreatmentAcross the country, survivors' opinions and actions are influencing cancer care.
by Stephen Ornes
-
Forward Look
Diagnosis: DebtEven for the insured, cancer care can be a financial burden.
by Jocelyn Selim
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
